MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases

doi:10.3748/wjg.14.1378

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3391)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

270

HTML

2591

Figures (1-4)

326

Tables (1-1)

204

Sum=3391

Mar 7, 2008 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 7, 2008; 14(9): 1378-1382
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1378

Full Size Figure Download Figure

Figure 1 Growth inhibition of pancreatic cancer cells by MK615. MK615 significantly inhibited the growth of PANC1, PK1, and PK45H cells in a dose-dependent manner (^aP < 0.05). Cells were cultured for 48 h. The assay was carried out in triplicate.

Citation: Okada T, Sawada T, Osawa T, Adachi M, Kubota K. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World J Gastroenterol 2008; 14(9): 1378-1382
URL: https://www.wjgnet.com/1007-9327/full/v14/i9/1378.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1378